Resistance to ErbB2 tyrosine kinase inhibitors in breast cancer is mediated by calcium-dependent activation of RelA. (Q39745109)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Resistance to ErbB2 tyrosine kinase inhibitors in breast cancer is mediated by calcium-dependent activation of RelA. |
scientific article |
Statements
1 reference
Resistance to ErbB2 tyrosine kinase inhibitors in breast cancer is mediated by calcium-dependent activation of RelA. (English)
1 reference
Wenle Xia
1 reference
Sarah Bacus
1 reference
Intisar Husain
1 reference
Leihua Liu
1 reference
Sumin Zhao
1 reference
Zuguo Liu
1 reference
M Arthur Moseley
1 reference
J Will Thompson
1 reference
Franklin L Chen
1 reference
Kevin M Koch
1 reference
Neil L Spector
1 reference
2 February 2010
1 reference
1 reference
Identifiers
1 reference